Evidence & IP
We share reported validation, intellectual property, and grant milestones with clear limits. Investors and research partners should consider the underlying methods and records alongside each headline claim.
SIPL reports 97% agreement with the HAM-D clinical standard across 500+ assessments at RML Hospital. Agreement is a reported validation metric, not a claim of diagnostic accuracy. Study design, cohort details, and limitations should be reviewed alongside the headline figure.
SIPL reports Indian Patent No. 202511025669 and an active WIPO PCT filing. Patent scope, ownership, jurisdiction, and current status should be confirmed through the relevant patent records during diligence.
SIPL reports support through the BIRAC Grand Challenges India GCE-III programme for product development and validation. Grant support is not itself evidence of clinical performance or commercial adoption.
A public bibliography and detailed validation protocol are not listed on this page. For supporting records, methodology, and current IP documentation, please contact SIPL.
Request supporting information